Summit Therapeutics
SMMT
SMMT
61 hedge funds and large institutions have $34.6M invested in Summit Therapeutics in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
21% more call options, than puts
Call options by funds: $5.59M | Put options by funds: $4.63M
2.44% more ownership
Funds ownership: 1.59% → 4.03% (+2.4%)
Holders
61
Holding in Top 10
–
Calls
$5.59M
Puts
$4.63M
Top Buyers
| 1 | +$8.5M | |
| 2 | +$2.84M | |
| 3 | +$2.05M | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$1.3M |
| 5 |
AIC
AWM Investment Company
New York
|
+$1.27M |
Top Sellers
| 1 | -$563K | |
| 2 | -$514K | |
| 3 | -$199K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$92.3K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$65.4K |